Be a Smart Investor
Thursday, May 5, 2016
Healthy biotech M&A?
Discussing the impact of biotech deals on the sector overall, and whether Sanofi's offer for Medivation will pass, with Michael King, JMP Securities, and Les Funtleyder, E Squared Capital.
from Mergers and Acquisitions http://ift.tt/1SPQJXC
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment